Dr. Remy Durand brings over 10 years of experience in life sciences business development, investing, management consulting, and research. Prior to Alpine Immune Sciences, Remy was a Vice President on the life sciences investment team at Frazier Healthcare Partners, one of the first dedicated healthcare investment firms. During his time at Frazier, Dr. Durand served as a board observer or director on multiple companies, including Alpine Immune Sciences (NASDAQ:ALPN), Aptinyx (NASDAQ:APTX), and Scout Bio. Earlier in his career, Dr. Durand held roles of increasing responsibility at GE Ventures and L.E.K. Consulting, a premier strategic advisor to the life sciences industry.
Dr. Durand received his Ph.D. in Bioengineering from Stanford University in the lab of Karl Deisseroth.